Colorectal cancer (CRC) ranks as the third most prevalent malignant tumor globally1,2,3. Signet ring cell carcinoma (SRCC), a rare subtype of CRC, comprises approximately 1% of cases and is characterized by abundant intracellular mucin displacing the cell nucleus1,2,4. SRCC is often associated with younger patients, has a higher prevalence in females, and has advanced tumor stages at diagnosis. Compared to colorectal adenocarcinoma, SRCC shows poorer differentiation, a higher risk of distant metastasis, and a 5-year survival rate of only 12%-20%5,6. Developing an accurate and effective prognostic model for SRCC is crucial for optimizing treatment strategies and improving clinical outcomes.
This study aims to construct a robust prognostic model for SRCC patients using advanced statistical approaches, including machine learning (ML) and competing risk models. These methodologies can accommodate complex relationships in clinical data, offering individualized risk assessments and surpassing traditional methods in predictive accuracy. Machine learning models, such as Random Forest, XGBoost, and Neural Networks, excel in processing high-dimensional data and identifying intricate patterns. Studies have shown that AI models effectively predict survival outcomes in colorectal cancer, emphasizing ML's potential in clinical applications7,8. Complementing ML, competing risk models address multiple event types, such as cancer-specific mortality versus other causes of death, to refine survival analysis. Unlike traditional methods like the Kaplan-Meier estimator, competing risk models accurately estimate the marginal probability of events in the presence of competing risks, providing more precise survival assessments8. Integrating ML and competing risk analysis enhances predictive performance, offering a powerful framework for personalized prognostic tools in SRCC9,10,11.
Lymph node metastasis significantly influences prognosis and recurrence in CRC patients. While N-stage assessment in the TNM classification is critical, inadequate lymph node examination -- reported in 48%-63% of cases -- can lead to disease underestimation. To address this, alternative approaches like the lymph node ratio (LNR) and the log odds of positive lymph nodes (LODDS) have been introduced. LNR, the ratio of positive lymph nodes (PLNs) to total lymph nodes (TLNs), is less affected by TLN count and serves as a prognostic factor in CRC. LODDS, the logarithmic ratio of PLNs to negative lymph nodes (NLNs), has shown superior predictive ability in both gastric SRCC and colorectal cancer10,11. Machine learning has been increasingly applied in oncology, with models improving risk stratification and prognostic predictions across various cancers, including breast, prostate, and lung cancers12,13,14. However, its application in colorectal SRCC remains limited.
This study seeks to bridge this gap by integrating LODDS with ML and competing risk models to create a comprehensive prognostic tool. By evaluating the prognostic value of LODDS and leveraging advanced predictive techniques, this research aims to enhance clinical decision-making and improve outcomes for SRCC patients.